Caspase 9 (CASP9) (NM_001229) Human Recombinant Protein
CAT#: TP761193
Purified recombinant protein of Human caspase 9, apoptosis-related cysteine peptidase (CASP9), transcript variant alpha, full length, with N-terminal HIS tag, expressed in E. coli, 50ug
View other "Caspase 9" proteins (6)
Need it in bulk or customized? Get a free quote |
CNY 2,040.00
Cited in 1 publication. |
Specifications
Product Data | |
Species | Human |
Expression Host | E. coli |
Expression cDNA Clone or AA Sequence |
A DNA sequence encoding human full-length CASP9
|
Tag | N-His |
Predicted MW | 46.1 kDa |
Concentration | >0.05 µg/µL as determined by microplate BCA method |
Purity | > 80% as determined by SDS-PAGE and Coomassie blue staining |
Buffer | 50 mM Tris-HCl, pH 8.0, 8 M urea |
Note | For testing in cell culture applications, please filter before use. Note that you may experience some loss of protein during the filtration process. |
Storage | Store at -80°C. |
Stability | Stable for 12 months from the date of receipt of the product under proper storage and handling conditions. Avoid repeated freeze-thaw cycles. |
Reference Data | |
RefSeq | NP_001220 |
Locus ID | 842 |
UniProt ID | P55211 |
Refseq Size | 2034 |
Cytogenetics | 1p36.21 |
Refseq ORF | 1248 |
Synonyms | APAF-3; APAF3; ICE-LAP6; MCH6; PPP1R56 |
Summary | This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. This protein can undergo autoproteolytic processing and activation by the apoptosome, a protein complex of cytochrome c and the apoptotic peptidase activating factor 1; this step is thought to be one of the earliest in the caspase activation cascade. This protein is thought to play a central role in apoptosis and to be a tumor suppressor. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2013] |
Protein Families | Druggable Genome, Protease, Stem cell - Pluripotency |
Protein Pathways | Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), Apoptosis, Colorectal cancer, Endometrial cancer, Huntington's disease, Non-small cell lung cancer, p53 signaling pathway, Pancreatic cancer, Parkinson's disease, Pathways in cancer, Prostate cancer, Small cell lung cancer, VEGF signaling pathway, Viral myocarditis |
Citations (1)
The use of this Proteins has been cited in the following citations: |
---|
Blockade of autophagy enhances proapoptotic potential of BI-69A11, a novel Akt inhibitor, in colon carcinoma.
,null,
European journal of pharmacology
,PubMed ID 26306675
[CASP9]
|
Documents
FAQs |
SDS |
Resources
蛋白相关资源 |
Other Versions
SKU | Description | Size | Price |
---|---|---|---|
LC400491 | CASP9 HEK293T cell transient overexpression lysate (as WB positive control) |
CNY 900.00 |
|
LC409796 | CASP9 HEK293T cell transient overexpression lysate (as WB positive control) |
CNY 900.00 |
|
LY400491 | Transient overexpression lysate of caspase 9, apoptosis-related cysteine peptidase (CASP9), transcript variant alpha |
CNY 3,080.00 |
|
LY409796 | Transient overexpression lysate of caspase 9, apoptosis-related cysteine peptidase (CASP9), transcript variant beta |
CNY 3,080.00 |
|
PH313375 | CASP9 MS Standard C13 and N15-labeled recombinant protein (NP_127463) |
CNY 19,520.00 |
|
TP313375 | Recombinant protein of human caspase 9, apoptosis-related cysteine peptidase (CASP9), transcript variant beta, 20 µg |
CNY 2,900.00 |
其它Caspase 9产品